[Note: I’m pasting here the action alert from Jennifer McLennan, Director of Communications, Scholarly Publishing & Academic Resources Coalition (SPARC). FGI has no affiliation with SPARC, but this is an extremely important issue]
Last week, the Chairman of the House Judiciary Committee (Rep. John Conyers, D-MI) re-introduced a bill that would reverse the NIH Public Access Policy and make it impossible for other federal agencies to put similar policies into place. The legislation is H.R. 801: the “Fair Copyright in Research Works Act”.
Please contact your Representative no later than February 28, 2009 to express your support for public access to taxpayer-funded research and ask that he or she oppose H.R.801. Contact your Representative directly using the contact information and draft letter below, or via the ALA legislative action center. As always, kindly let us know what action you’re able to take, via email to stacie [at] arl [dot] org.
H.R. 801 is designed to amend current copyright law and create a new category of copyrighted works (Section 201, Title 17). In effect, it would:
- Prohibit all U.S. federal agencies from conditioning funding agreements to require that works resulting from federal support be made publicly available if those works are either: a) funded in part by sources other than a U.S. agency, or b) the result of “meaningful added value” to the work from an entity that is not party to the agreement.
- Prohibit U.S. agencies from obtaining a license to publicly distribute, perform, or display such work by, for example, placing it on the Internet.
- Stifle access to a broad range of federally funded works, overturning the crucially important NIH Public Access Policy and preventing other agencies from implementing similar policies.
- Because it is so broadly framed, the proposed bill would require an overhaul of the well-established procurement rules in effect for all federal agencies, and could disrupt day-to-day procurement practices across the federal government.
- Repeal the longstanding “federal purpose” doctrine, under which all federal agencies that fund the creation of a copyrighted work reserve the “royalty-free, nonexclusive right to reproduce, publish, or otherwise use the work” for any federal purpose. This will severely limit the ability of U.S. federal agencies to use works that they have funded to support and fulfill agency missions and to communicate with and educate the public.
Because of the NIH Public Access Policy, millions of Americans now have access to vital health care information through the PubMed Central database. Under the current policy, nearly 3,000 new biomedical manuscripts are deposited for public accessibility each month. H.R.801 would prohibit the deposit of these manuscripts, seriously impeding the ability of researchers, physicians, health care professionals, and families to access and use this critical health-related information in a timely manner.
All supporters of public access — researchers, libraries, campus administrators, patient advocates, publishers, and others — are asked to contact their Representatives to let them know you support public access to federally funded research and oppose H.R. 801. Again, the proposed legislation would effectively reverse the NIH Public Access Policy, as well as make it impossible for other federal agencies to put similar policies into place.
Thank you for your support and continued persistence in supporting this policy. You know the difference constituent voices can make on Capitol Hill.
If you have any questions, don’t hesitate to contact Heather or myself anytime.
Director of Communications
(The Scholarly Publishing & Academic Resources Coalition)
(202) 296-2296 ext 121
jennifer [at] arl [dot] org
Please consider the environment before printing this e-mail.
Draft letter text:
On behalf of [your organization], I strongly urge you to oppose H.R. 801, “the Fair Copyright in Research Works Act,” introduced to the House Judiciary Committee on February 3, 2009. This bill would amend the U.S. Copyright Code, prohibiting federal agencies from requiring as a condition of funding agreements public access to the products of the research they fund. This will significantly inhibit our ability to advance scientific discovery and to stimulate innovation in all scientific disciplines.
Most critically, H.R. 810 would reverse the National Institutes of Health (NIH) Public Access Policy, prohibit American taxpayers from accessing the results of the crucial biomedical research funded by their taxpayer dollars, and stifle critical advancements in life-saving research and scientific discovery.
Because of the NIH Public Access Policy, millions of Americans now have access to vital health care information from the NIH’s PubMed Central database. Under the current policy, nearly 3,000 new biomedical manuscripts are deposited for public accessibility each month. H.R.801 would prohibit the deposit of these manuscripts, seriously impeding the ability of researchers, physicians, health care professionals, and families to access and use this critical health-related information in a timely manner.
H.R. 801 affects not only the results of biomedical research produced by the NIH, but also scientific research coming from all other federal agencies. Access to critical information on energy, the environment, climate change, and hundreds of other areas that directly impact the lives and well being of the public would be unfairly limited by this proposed legislation.
[Why you support taxpayer access and the NIH policy].
The NIH and other agencies must be allowed to ensure timely, public access to the results of research funded with taxpayer dollars. Please oppose H.R.801.
[END LETTER TEXT]
Members of the House Committee on the Judiciary
(For other Members of Congress, please see www.house.gov or use the ALA legislative action center.
Name Fax number State:
Rep. Trent Franks 202-225-6328 AZ
Rep. Howard Berman 202-225-3196 CA
Rep. Zoe Lofgren 202-225-3336 CA
Rep. Maxine Waters 202-225-7854 CA
Rep. Brad Sherman 202-225-5879 CA
Rep. Adam Schiff 202-225-5828 CA
Rep. Linda Sánchez 202-226-1012 CA
Rep. Elton Gallegly 202-225-1100 CA
Rep. Dan Lungren 202-226-1298 CA
Rep. Darrell Issa 202-225-3303 CA
Rep. Robert Wexler 202-225-5974 FL
Rep. Debbie Wasserman Schultz 202-226-2052 FL
Rep. Tom Rooney 202-225-3132 FL
Rep. Hank Johnson 202-226-0691 GA
Rep. Steve King 202-225-3193 IA
Rep. Luis Gutierrez 202-225-7810 IL
Rep. William D. Delahunt 202-225-5658 MA
Rep. John Conyers, Jr. 202-225-0072 MI
Rep. Gregg Harper 202-225-5797 MS
Rep. Melvin Watt 202-225-1512 NC
Rep. Howard Coble 202-225-8611 NC
Rep. Jerrold Nadler 202-225-6923 NY
Rep. Anthony Weiner 202-226-7253 NY
Rep. Dan Maffei 202-225-4042 NY
Rep. Jim Jordan 202-226-0577 OH
Res. Comm. Pedro Pierluisi 202-225-2154 PR – At large
Rep. Steve Cohen 202-225-5663 TN
Rep. Sheila Jackson Lee 202-225-3317 TX
Rep. Charles A. Gonzalez 202-225-1915 TX
Rep. Lamar Smith 202-225-8628 TX
Rep. Louie Gohmert 202-226-1230 TX
Rep. Ted Poe 202-225-5547 TX
Rep. Jason Chaffetz 202-225-5629 UT
Rep. Rick Boucher 202-225-0442 VA
Rep. Robert Scott 202-225-8354 VA
Rep. Bob Goodlatte 202-225-9681 VA
Rep. J. Randy Forbes 202-226-1170 VA
Rep. Tammy Baldwin 202-225-6942 WI
Rep. F. James Sensenbrenner, Jr. 202-225-3190 WI
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.